Related references
Note: Only part of the references are listed.Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
Paul A. Dutchak et al.
CELL (2012)
βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
Xunshan Ding et al.
CELL METABOLISM (2012)
Understanding the Physical Interactions in the FGF21/FGFR/β-Klotho Complex: Structural Requirements and Implications in FGF21 Signaling
Junming Yie et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys
Murielle M. Veniant et al.
ENDOCRINOLOGY (2012)
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
Matthew J. Potthoff et al.
GENES & DEVELOPMENT (2012)
Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress
Chaofeng Yang et al.
NUTRITION & METABOLISM (2012)
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
Chaofeng Yang et al.
PLOS ONE (2012)
FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
Murielle M. Veniant et al.
PLOS ONE (2012)
Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ
Wei Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hormone-like fibroblast growth factors and metabolic regulation
Yun Chau Long et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid Relationship With Plasma FGF21 and Body Adiposity
Bee K. Tan et al.
DIABETES (2011)
Therapeutic utilities of fibroblast growth factor 19
Xinle Wu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
The FGFR D3 Domain Determines Receptor Selectivity For Fibroblast Growth Factor 21
Jamila Gupte et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Receptor Antibodies as Novel Therapeutics for Diabetes
Siegfried Ussar et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1
Ai-Luen Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
FGF21 reloaded: challenges of a rapidly growing field
Alexei Kharitonenkov et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
David A. Sarruf et al.
DIABETES (2010)
FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
Xinle Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Klementina Fon Tacer et al.
MOLECULAR ENDOCRINOLOGY (2010)
Relevant use of Klotho in FGF19 subfamily signaling system in vivo
Ken-ichi Tomiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis
Michael K. Badman et al.
ENDOCRINOLOGY (2009)
FGF21 N- and C-termini play different roles in receptor interaction and activation
Junming Yie et al.
FEBS LETTERS (2009)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
Alexei Kharitonenkov et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c
Masashi Suzuki et al.
MOLECULAR ENDOCRINOLOGY (2008)
Klotho-related protein is a novel cytosolic neutral β-glycosylceramidase
Yasuhiro Hayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Downstream processing of monoclonal antibodies - Application of platform approaches
Abhinav A. Shukla et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways
Wolf Wente et al.
DIABETES (2006)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals
R Trokovic et al.
EMBO JOURNAL (2003)
Molecular cloning and expression analyses of mouse ßklotho, which encodes a novel Klotho family protein
S Ito et al.
MECHANISMS OF DEVELOPMENT (2000)
Share Paper
